Effect of a Mobile Application on Stoma Adaptation and Quality of Life
NCT ID: NCT07260539
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
66 participants
INTERVENTIONAL
2026-01-01
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Mobile Health Education on Adaptation to Stoma, Self-efficacy, and Peristomal Lesions
NCT05664503
The Effect of Education and Counseling Given to People With Stoma by Telephone on Stoma Compliance and Complications
NCT06189300
Vıdeo-Assısted Stoma Care Traınıng Gıven To Patıents Wıth Stoma Adaptıng To Stoma and Complıcatıons
NCT06672211
The Impact of Education Using a Stoma Care Training Belt
NCT06391398
Evaluation of the Effect of Two Different Methods on Stoma Compliance and Self-efficacy
NCT05308693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The trial will be conducted at the Stomatherapy Unit of Gazi University Health Research and Application Center in Ankara, Türkiye.
Participants and sample size: Adults (≥18 years) undergoing ostomy surgery for the first time and expected to have a permanent ostomy or an ostomy lasting ≥6 months will be screened. Additional inclusion criteria include Turkish literacy, no major mental/physical/communication barriers, ownership of an iOS/Android smartphone with internet access, ability to use mobile applications, and WhatsApp use for digital form submission.
Individuals receiving concurrent stoma education/counseling from another institution or professional during follow-up will be excluded.
Based on power analysis (mixed ANOVA, Cohen f=0.40, α=0.05, power=99.7%, r=0.50), a minimum of 60 participants is required; allowing for \~10% attrition, the target enrollment is 66 participants (1:1 allocation).
Randomization and masking: Participants will be randomized 1:1 to intervention (Group A) or control (Group B) using block randomization via SealedEnvelope.com. Eleven fixed blocks of six participants will be generated, with three participants assigned to each group per block.
Randomization will be performed by an independent person not involved in data collection. The trial is single-blind: participants will not be informed of their group assignment; researchers delivering the intervention will be unblinded.
Intervention: All participants will receive the unit's standard pre-discharge stoma education and routine follow-up guidance.
In the intervention group, the "Stomaterapi-M" mobile application will be installed on discharge day with researcher guidance. For six months, participants will access structured educational materials (text and videos), nurse counseling through in-app messaging and scheduled video appointments, and a planned monitoring module for symptom/complication tracking. Monitoring frequency is weekly during month 1, bi-weekly during month 2, and monthly during months 3-6, with reminder notifications sent before each planned entry.
Participants who miss three consecutive monitoring/counseling sessions, cannot actively use the app, withdraw consent, or submit incomplete outcome forms will be removed from the study.
Control: The control group will receive standard care only, including routine stomatherapy education, counseling, and clinic follow-ups. Outcomes will be collected digitally via
Outcome measures and timeline:
Primary outcomes are (1) stoma adaptation measured with the Ostomy Adjustment Inventory (OAI), and (2) stoma-related quality of life measured with the Adaptation of Quality of Life Scale (AQLS).
These outcomes will be assessed at post-discharge day 15 and at months 1, 3, and 6.
Secondary outcome is app usability measured with the Mobile Application Usability Scale (MAUS) in the intervention group at month 6.
To minimize loss to follow-up, reminder messages/notifications will be sent to both groups at each assessment point.
Data management and analysis: Participants will be coded as A/B without linking codes to personal identifiers. Analyses will follow the intention-to-treat principle.
Group×time effects on OAI and AQLS will be analyzed using mixed two-factor repeated measures ANOVA; non-parametric equivalents will be applied if assumptions are not met. Between-group comparisons at each time point will use independent samples t-test or Mann-Whitney U test, and within-group changes will use repeated measures ANOVA or Friedman test. Significance will be set at p\<0.05 (and p\<0.01 where appropriate).
Ethics and funding: Ethical approval has been obtained from the Gazi University Ethics Committee (Approval No. E-77082166-302.08.01-1018511) and institutional permission from Gazi University Health Research and Application Center.
Written informed consent will be obtained from all participants. The study is funded by Gazi University Scientific Research Projects (BAP) under grant TDK-2025-10011.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Participants will install the "Stomaterapi-M" mobile application on discharge day and will receive structured education (texts/videos), nurse counseling via in-app messaging and scheduled video calls, and planned monitoring for 6 months (weekly in month 1, bi-weekly in month 2, monthly in months 3-6) in addition to standard care.
Stomaterapi-M Mobile Application Support
Participants will use the "Stomaterapi-M" mobile application for 6 months starting on discharge day. The app provides structured stoma education (texts and videos), nurse counseling via in-app messaging and scheduled video calls, and a planned monitoring module. Monitoring frequency is weekly during month 1, bi-weekly during month 2, and monthly during months 3-6, with reminder notifications before each planned entry.
Standard Care
Participants will receive routine stomatherapy education, counseling, and follow-up provided by the clinic. Outcome assessments will be completed digitally at the same time points as the intervention group, without access to the mobile application.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stomaterapi-M Mobile Application Support
Participants will use the "Stomaterapi-M" mobile application for 6 months starting on discharge day. The app provides structured stoma education (texts and videos), nurse counseling via in-app messaging and scheduled video calls, and a planned monitoring module. Monitoring frequency is weekly during month 1, bi-weekly during month 2, and monthly during months 3-6, with reminder notifications before each planned entry.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ferzan Kalaycı Emek
RESEARCH ASSISTANT
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TDK-2025-10011
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
GU-HM-FKE-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.